Taichung Commercial Bank Co., Ltd. (TPE:2812)

Market Cap	122.79B
Revenue (ttm)	18.61B
Net Income (ttm)	8.38B
Shares Out	5.52B
EPS (ttm)	1.51
PE Ratio	14.74
Forward PE	n/a
Dividend	0.39 (1.76%)
Ex-Dividend Date	Aug 13, 2025

Volume	5,383,126
Average Volume	7,332,889
Open	22.20
Previous Close	22.20
Day's Range	22.05 - 22.35
52-Week Range	16.00 - 22.90
Beta	0.18
RSI	57.40
Earnings Date	Aug 13, 2025

About CTI BioPharma

Taichung Commercial Bank Co., Ltd. provides various banking products and services in Taiwan. The company offers various deposit products, such as savings account and time deposit accounts, cash, foreign currency demand deposits, and travel checks and remittance; corporate finance services, which include corporate loans, letter of credit, collections, and factoring and forfaiting, as well as account information, deposits, payments, accounts receivable financing, hedging strategies, financial instruments, and consultation services; and personal m...

• Industry: Banks - Regional
• Sector: Financials
• Founded: 1952
• Employees: 1,809
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 2812

Financial Performance

In 2024, Taichung Commercial Bank's revenue was 18.20 billion, an increase of 14.96% compared to the previous year's 15.83 billion. Earnings were 8.29 billion, an increase of 21.56%.